Farther Finance Advisors’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $44.1K | Buy |
5,829
+5,779
| +11,558% | +$43.7K | ﹤0.01% | 2190 |
|
|
2025
Q1 | $266 | Sell |
50
-8
| -14% | -$43 | ﹤0.01% | 3897 |
|
|
2024
Q4 | $334 | Sell |
58
-76
| -57% | -$438 | ﹤0.01% | 3528 |
|
|
2024
Q3 | $1.39K | Sell |
134
-4
| -3% | -$41 | ﹤0.01% | 3128 |
|
|
2024
Q2 | $1.8K | Buy |
138
+10
| +8% | +$131 | ﹤0.01% | 2835 |
|
|
2024
Q1 | $2.18K | Sell |
128
-69
| -35% | -$1.18K | ﹤0.01% | 2456 |
|
|
2023
Q4 | $1.85K | Buy |
197
+185
| +1,542% | +$1.74K | ﹤0.01% | 2461 |
|
|
2023
Q3 | $134 | Buy |
+12
| New | +$134 | ﹤0.01% | 2524 |
|